Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 85

WhiteSource wires in $75m

Microsoft's M12 unit returned to participate in a series D round that hiked the cybersecurity software provider's overall funding to $121m.

Apr 8, 2021

JGC invests $40m in NuScale Power

JGC Holdings bacame the latest investor in the modular nuclear reactor technology developer, which emerged out of Oregon State University.

Apr 8, 2021

Nucleix knuckles down to raise $55m

Lilly Asia Ventures contributed to a $55m round that will support work on Nucleix's early-stage lung cancer biopsy.

Apr 8, 2021

Vesta Healthcare takes care with $65m

CareCentrix, Kaiser Permanente and Nationwide have all returned to take part in a round for the remote care technology provider, lifting its overall funding to $95m.

Apr 8, 2021

Allm calls in $50m in series A

Capital Medica, Cyberdyne, Eisai, Financial Agency, Mitsui, Mixi, Opt, NID, Philips, Sompo and Vector all took part in a round for the medical ICT tool developer.

Apr 7, 2021

JGC invests $40m in NuScale Power

JGC Holdings bacame the latest investor in the modular nuclear reactor technology developer, which is already backed by a number of corporates.

Apr 7, 2021

Alloy Therapeutics amalgamates $75m

Alexandria Real Estate Equities was among the participants as the drug discovery technology provider closed its series C round.

Apr 6, 2021

StashFin stacks up $40m

The neobank's latest round included Saison Capital, Tencent Cloud Europe and existing backers Snow Leopard Ventures and Positive Moves.

Apr 6, 2021

Kakao Mobility gears up with $50m

Google has provided fresh funding for Kakao’s on-demand ride hailing spinoff two months after it received $200m from Carlyle Group.

Apr 6, 2021

Immune-Onc gets $73m funding influx

The cancer therapy developer, which is commercialising research from University of Texas, has raised series B1 and B2 financing.

Apr 1, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here